Bitesize Bio's Vicki Ronaldson this week says that "despite the temptation to play down past academic pursuits amongst more corporate peers, a look at the top level management, or even the board, of any global life science or technology company will reveal a high percentage of PhDs, all of whom started out at the bench." But, she says, transitioning from academic research to the corporate world can be tough.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.